Diabetes, heart disease, cancer, and other chronic, non-communicable diseases represent 80% of premature deaths worldwide and place substantial economic burdens on our societies. Abt Global supports early detection, prevention, and treatment of these widespread conditions, to mitigating their impact on quality of life and healthcare expenses. We collaborate with clients like the U.S. Centers for Disease Control and Prevention to inform policy and program decisions through rigorous studies and evaluations. Our mixed methods approach for data collection and strategic communications expertise inform decisions to make healthcare systems more efficient and resilient.
Expertise
- Qualitative Research and Evaluations
- Building Health Systems Capacity
- Evaluating Health Impacts
- Behavioral Change Communications Campaigns
Clients Include

Centers for Disease Control and Prevention

Agency for Healthcare Research and Quality

National Institutes of Health

National Cancer Institute

National Heart, Lung, and Blood Institute

National Institute of Aging

Food & Drug Administration